Verona Pharma (VRNA)
NASDAQ: VRNA
· Real-Time Price · USD
105.26
-0.01 (-0.01%)
At close: Aug 15, 2025, 3:59 PM
105.27
0.01%
After-hours: Aug 15, 2025, 04:15 PM EDT
Verona Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -16.38M | -33.83M | -42.96M | -70.91M | -25.78M | -14.25M | -14.69M | -8.81M | -16.74M | -10.45M | -15.65M | -17.77M | -24.84M | -23.26M | 11.05M | -22.07M | -21.29M |
Depreciation & Amortization | 949K | 259K | 266K | 270.3K | 262.85K | 209.81K | 155K | 157K | 157K | 151K | 157K | 165K | 163K | 162K | 162K | 152K | 153K |
Stock-Based Compensation | 37.48M | 13.74M | 7.65M | 15.59M | 4.26M | 4.57M | 5.08M | 5.07M | 4.29M | 4.5M | 2.82M | 3.05M | 3.75M | 4.19M | 4.94M | 7.45M | 8.85M |
Other Working Capital | n/a | 9.74M | -25.55M | 26.74M | 6.6M | -1.41M | -2.66M | -12.3M | 3.03M | 5.61M | -7.96M | -8.46M | 7.22M | -7.76M | 20.94M | -2.57M | -7.03M |
Other Non-Cash Items | -33.61M | 5.87M | 13.68M | 13.11M | 4.14M | 2.37M | 48K | 48K | -841K | -2.45M | 3.9M | 2.19M | 1.17M | 53K | 54K | 82K | 50K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -3.44M | 1.01M | -740K | n/a | n/a | n/a | n/a | n/a | -734K | -14.3M | -2.74M | 352K |
Change in Working Capital | n/a | -14.88M | -41.29M | 34.03M | 7.27M | 132.05K | -4.33M | -17.04M | 7.36M | 504K | -9.32M | -7.16M | 5.24M | 2.27M | 20.92M | -3.08M | -6.67M |
Operating Cash Flow | -11.56M | -28.84M | -62.66M | -16.76M | -13.97M | -10.42M | -12.73M | -21.31M | -5.78M | -7.74M | -18.09M | -19.52M | -14.51M | -17.32M | 22.82M | -20.2M | -18.55M |
Capital Expenditures | n/a | -535K | 45.01K | -29.02K | -15.99K | n/a | n/a | n/a | n/a | -280.39 | 122.67 | -28.82K | n/a | -1K | -11K | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -535K | n/a | -45K | n/a | -16K | n/a | n/a | n/a | n/a | n/a | n/a | -176 | n/a | -12K | n/a | n/a | n/a |
Investing Cash Flow | -535K | -535K | 13.00 | -29.02K | -15.99K | -37.07K | n/a | n/a | n/a | -280.39 | 122.67 | -29K | n/a | -1K | -11K | n/a | n/a |
Debt Repayment | n/a | -100M | n/a | 70.24M | n/a | 22.52M | n/a | n/a | 10M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | 4M | n/a | -1.17M | -2.83M | n/a | n/a | n/a | n/a | -1.94M | n/a | -566.02K | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 13.46M | 96.66M | -10.77M | 96.59M | -3.12M | 5.17M | 48K | 77K | 1.83M | 2.61M | -10.11M | -689K | -793K | -901K | -2.17M | -3.78M | n/a |
Financial Cash Flow | 13.46M | 94.16M | -7.09M | 166.52M | -2.76M | 24.07M | 48K | 124K | 68.69M | 2.61M | 139.62M | -689K | -726K | -901K | -1.82M | -3.4M | n/a |
Net Cash Flow | 1.66M | 63.72M | -68.56M | 149.72M | -16.89M | 14.41M | -13.36M | -20.69M | 63.59M | -3.87M | 120.19M | -21.25M | -15.62M | -18.17M | 20.51M | -23.56M | -18.39M |
Free Cash Flow | -11.56M | -29.37M | -62.66M | -16.78M | -13.98M | -10.42M | -12.73M | -21.31M | -5.78M | -7.74M | -18.09M | -19.55M | -14.51M | -17.32M | 22.81M | -20.2M | -18.55M |